Cormorant Asset Management, LP, 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT), bought 1,700,000 shares at $12.36 ($20.2M) on 2024-05-06, disclosed to the SEC on 2024-05-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.70 | 642,847 | $7.5M | 37.3% |
| 2 | $11.70 | 642,847 | $7.5M | 37.3% |
| 3 | $12.36 | 207,153 | $2.6M | 12.7% |
| 4 | $12.36 | 207,153 | $2.6M | 12.7% |
| Total | $11.86 avg | 1,700,000 | $20.2M | 100% |
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| CRBP | BUY | 2024-02-06 | $14.3M | — | Filing → |
| EYPT | BUY | 2024-01-11 | $17.1M | — | Filing → |